When Philips Respironics in 2021 recalled millions of devices for treating sleep apnea, the company warned users of potential ill effects including kidney and liver damage in connection with foam used in the CPAP machines. Yet those claims aren’t eligible for compensation under a $1.1 billion settlement. Jenna Greene looks at why not, and how tricky it can be to draw a line between exposure and illness in toxic tort cases that involve thousands of people but have no “signature” injury. Read more.
Check out other recent pieces from our columnists: Alison Frankel and Jenna Greene
|